Genentech Owns a Patent on Tissue Plasminogen Activator (TPA),which Is

question 138

Essay

Genentech owns a patent on tissue plasminogen activator (TPA),which is an enzyme that helps the body break down blood clots.TPA is particularly valuable to cardiac patients,since it often allows heart problems to be treated with medication rather than surgery.Recently,however,firms in the medical industry have come under fire from some members of Congress and the press for charging high prices and earning monopoly profits.Do you think cardiac patients would benefit if the government stripped Genentech and other pharmaceutical firms of their patents?

---

Definitions:

Fixed Asset

Long-term tangible assets held for business use and not expected to be converted to cash in the coming fiscal year, such as buildings, machinery, and equipment.

Direct Method

An approach to preparing the cash flow statement that lists actual cash inflows and outflows from operating activities.

Operating Activities

The day-to-day actions and transactions that relate to the primary operations of a business, such as sales and purchasing.

Cash Payments

Cash payments refer to transactions where cash is transferred from one party to another, typically as a method of settling debts or paying for goods and services.